跳轉至內容
Merck
全部照片(1)

重要文件

Y0000612

Dopexamine dihydrochloride

European Pharmacopoeia (EP) Reference Standard

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C22H32N2O2 · 2HCl
CAS號碼:
分子量::
429.42
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

dopexamine

製造商/商標名

EDQM

應用

pharmaceutical (small molecule)

形式

neat

儲存溫度

2-8°C

SMILES 字串

[Cl-].[Cl-].N(CCCCCCNCCc2ccccc2)CCc1cc(c(cc1)O)O.[H+].[H+]

InChI

1S/C22H32N2O2.2ClH/c25-21-11-10-20(18-22(21)26)13-17-24-15-7-2-1-6-14-23-16-12-19-8-4-3-5-9-19;;/h3-5,8-11,18,23-26H,1-2,6-7,12-17H2;2*1H

InChI 密鑰

VPDULUNRSQWWJB-UHFFFAOYSA-N

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Dopexamine dihydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Dopexamine and survival: areas of consistency.
R Pearse et al.
Anaesthesia, 64(11), 1258-1258 (2009-10-15)
Nour Eddine El Mokhtari et al.
European journal of medical research, 12(11), 563-567 (2007-11-21)
To examine the effects of a therapy with dopexamine/dopamine in comparison with a regimen of dobutamine/dopamine on the outcome of patients with profound cardiogenic shock. Twenty patients presenting with an acute cardiogenic shock assisted with mechanical ventilation, being refractory to
N E El Mokhtari et al.
European journal of medical research, 13(10), 459-463 (2008-11-15)
To examine the effects of a therapy with dopexamine/dopamine in comparison with a regimen of dobutamine/dopamine on the outcome of patients with profound cardiogenic shock. Twenty patients presenting with an acute cardiogenic shock assisted with mechanical ventilation, being refractory to
Shaman Jhanji et al.
Critical care (London, England), 14(4), R151-R151 (2010-08-12)
Post-operative outcomes may be improved by the use of flow related end-points for intra-venous fluid and/or low dose inotropic therapy. The mechanisms underlying this benefit remain uncertain. The objective of this study was to assess the effects of stroke volume
Meta-analyses of the effects of dopexamine in major surgery: do all roads lead to Rome?
J J Pandit
Anaesthesia, 64(6), 585-588 (2009-05-21)

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務